🧬 Cagrilintide;

Molecular Formula: C194H312N54O59S2
Molecular Weight: 4409.01 g/mol
CAS Number: 1415456‑99‑3

———————————–
🧬 Retatrutide;

Molecular Formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular Weight: ~4845.44 g/mol
CAS Number: 2381089‑83‑2

COA (certificate of analysis) provided: cagri_reta_5_5_10mg_COA99.59%

Purity: 99.59% HPLC

Product Video:

A cagrilintide + retatrutide amino blend is an interesting concept, but it helps to be very clear about what you’re combining. Both molecules are large, highly engineered polypeptides, not short research peptides—so “amino blend” in this context means a co‑formulated mixture of two long‑chain peptides, each with its own receptor‑targeting profile.
Below is a precise, technical breakdown so you can work with this accurately.

Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors, promoting significant fat loss (up to 24% in trials) through appetite suppression and increased energy expenditure. Cagrilintide, an amylin analog, boosts satiety and slows gastric emptying, complementing GLP-1 drugs but with a longer half-life (~10 days).

🧬 Amino Acid Counts
Cagrilintide: 37 amino acids Amylin receptor agonist Modified amylin analogue with lipidation
Retatrutide: 39 amino acids Triple agonist (GLP‑1 / GIP / Glucagon)
🧬 50/50 Blend — Total Amino Acids
If the blend is 1:1 by molar ratio:
Total amino acids = 37 + 39 = 76 amino acids
This is the total number of amino‑acid residues present across both molecules in the blend.
They do not fuse into a single 76‑aa peptide — it is simply the combined count of the two polypeptides present in equal proportion.
A “cagri + reta peptide blend” refers to a research‑only combination of cagrilintide and retatrutide, two investigational peptides often sold together for laboratory studies. Both components are not approved for medical use, and vendors explicitly state they are for research purposes only.

Cagri-Reta Blend is a powerful combination of two cutting-edge metabolic peptides: Cagrilintide (5mg) and Retatrutide (5mg).
This unique blend is designed to support research into weight management, glucose control, appetite regulation, and fat metabolism.

Cagrilintide, an amylin analog, is studied for appetite suppression and satiety, while Retatrutide, a triple agonist (GLP-1, GIP, and glucagon), is investigated for comprehensive metabolic improvements and energy expenditure.

Together, they form a potent research tool in the field of obesity and metabolic health studies.
🧪 What the Cagri + Reta Blend Is

Cagrilintide: An amylin analogue studied for appetite regulation and metabolic effects.

Retatrutide: A triple‑agonist peptide (GIP/GLP‑1/glucagon) under investigation for metabolic and weight‑related pathways.

Cagrireta blends: Commercial research mixtures combining both peptides in a single vial, typically lyophilized powder

These blends are not approved medications and are not intended for human consumption.

They are sold for laboratory, analytical, or in‑vitro research only.

Any dosing discussions online (e.g., Reddit or forums) are anecdotal and not medical guidance.

The GLP-3 and Cagrilintide peptide blend combines two distinct agents in one research-use-only format. GLP-3 is a triple-receptor agonist that engages GLP-1, GIP, and glucagon receptors, while Cagrilintide is a long-acting amylin-receptor analog that interacts with amylin receptors involved in gut-brain signaling pathways.
Together, the blend is investigated as a tool to study multi-pathway receptor activation, downstream signaling cascades, and metabolic pathway markers in animal and other non-clinical research models, not as a therapeutic regimen.

Reconstitute with BAC’s Water OnlyWhen reconstituting peptides, it is crucial to use bacteriostatic water (BAC) to ensure sterility and safety.
BAC water contains 0.9% Benzyl Alcohol and is bacteria-proof, making it the preferred choice for reconstitution.
This method helps preserve the integrity of the peptide and prevents contamination.
To reconstitute a peptide blend, follow these steps:Disinfect both vials and the stoppers with alcohol wipes.
Measure the required amount of BAC water based on the dosage.Mix the peptide powder with the measured BAC water in a sterile syringe.
Inject the solution into the vial and refrigerate at 2–8°C, protected from light.
Use the reconstituted solution within 4 weeks for best potency and safety.

Legal and Safety Information;
Quantum Peptides products are provided exclusively for laboratory research and educational use.
They are not approved for human or veterinary applications.
These materials are not intended to diagnose, treat, cure, or prevent any medical condition.
All use must adhere to applicable laws and regulatory requirements.

Photo shown is for illustration purpose containing as much information in the phtoto as possibl, Bottle labels wrap around the bottle and will vary slighly in design according to batch and prevents counterfeiting.